12 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.8% per year over the past 5 years.
Operating margin has expanded, at 35.9% in the latest year.
Free cash flow has grown 0.2% per year over the past 5 years.
Financial health
Total debt has grown faster than revenue (27.7% vs -0.8% per year).
Operating income covered interest expense 5.3× in the latest year, down from 8.4× 5 years ago.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1.2B
-$167M
39.5%
35.9%
-562.6%
-10.1%
$274M
—
$78M
2024
$1.2B
-$430M
38.7%
35.5%
-220.4%
-21.3%
$51M
—
$68M
2023
$1.2B
-$5M
36.6%
34.8%
-0.9%
-0.2%
$95M
—
$96M
2022
$1.7B
$212M
34.2%
27.1%
30.3%
7.7%
$171M
—
$77M
2021
$1.4B
$118M
36.9%
30.3%
17.5%
4.8%
$190M
—
$275M
2020
$1.2B
$181M
38.3%
32.7%
28.3%
7.8%
$270M
$1.3B
$258M
2019
$1.3B
$184M
37.3%
30.7%
34.6%
8.6%
$161M
$1.3B
$57M
2018
$1.1B
$169M
36.8%
28.3%
49.9%
12.9%
$158M
$759M
$78M
2017
$972M
$127M
33.8%
25.0%
45.5%
13.6%
$122M
$455M
$88M
2016
$908M
$35M
30.2%
18.0%
27.7%
4.2%
$71M
$492M
$31M
2015
—
$80M
—
—
15.5%
10.2%
-$29M
—
$32M
2014
—
$129M
—
—
—
18.0%
$37M
—
$20M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$314M
$35M
44.3%
0.0%
75.3%
2.3%
-$24M
—
$97M
Mar '26
$258M
$60M
45.1%
0.0%
153.7%
3.6%
-$12M
—
$95M
Dec '25
$255M
-$85M
34.4%
0.0%
-284.8%
-5.1%
$74M
—
$78M
Sep '25
$333M
$44M
40.2%
0.0%
31.5%
2.4%
$118M
—
$83M
Jun '25
$332M
-$147M
38.6%
0.0%
-121.4%
-7.8%
$67M
—
$77M
Mar '25
$248M
$21M
45.1%
0.0%
8.7%
1.0%
$15M
—
$72M
Dec '24
$263M
$17M
37.9%
30.6%
8.5%
0.8%
$40M
—
$68M
Sep '24
$334M
-$107M
39.4%
33.0%
-50.0%
-4.8%
$29M
—
$136M
Jun '24
$391M
-$284M
31.5%
25.9%
-99.6%
-12.5%
$12M
—
$107M
Mar '24
$340M
-$56M
29.3%
22.6%
-9.9%
-2.2%
-$29M
—
$89M
Dec '23
$372M
-$117M
16.0%
16.6%
-18.5%
-4.5%
$17M
—
$96M
Sep '23
$446M
$25M
28.9%
24.8%
3.5%
0.9%
$72M
—
$85M
Jun '23
$482M
$36M
31.8%
25.1%
5.0%
1.3%
$27M
—
$68M
Mar '23
$393M
$51M
33.2%
26.5%
7.0%
1.8%
-$20M
—
$78M
Dec '22
$384M
$16M
27.5%
19.4%
2.2%
0.6%
$49M
—
$77M
Sep '22
$482M
$75M
36.6%
28.7%
11.9%
3.2%
$64M
—
$72M
Jun '22
$420M
$60M
35.9%
28.8%
9.1%
2.5%
$61M
—
$131M
Mar '22
$383M
$61M
36.0%
31.1%
8.9%
2.5%
-$3M
—
$223M
Dec '21
$336M
$29M
31.3%
23.7%
4.3%
1.2%
$39M
—
$275M
Sep '21
$377M
-$4M
37.6%
31.7%
-0.7%
-0.2%
$75M
—
$269M
Valuation over time
How the market has priced NGVT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 11.6× (Mar '23) to 7.7× (Dec '23).
The price-to-sales ratio has risen from 1.5× (Mar '23) to 2.2× (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is NGVT growing its revenue and profit?
Over the past 5 years, Ingevity Corp's revenue has declined 0.8% per year. These are computed facts, not advice.
How much debt does NGVT have?
As of FY2025, Ingevity Corp reported — of total debt against $78M of cash; operating income covered interest expense 5.3×.
What is NGVT's profit margin?
In FY2025, gross margin was 39.5%, operating margin 35.9%, and net margin -14.3%.
What is NGVT's P/E ratio?
Ingevity Corp's P/E (TTM) is 46.94 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the NGVT stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 7.7× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.